What disease is tazetostat used to treat?

Tazemetostat is a targeted drug used to treat certain types of cancer. It is mainly used to treat epithelioid sarcoma (epithelioid sarcoma) and follicular lymphoma (follicular lymphoma). Epithelioid sarcoma is a rare soft tissue cancer that usually appears in the extremities of young adults but can also affect other parts of the body. Follicular lymphoma is a common non-Hodgkin lymphoma that mainly affects the lymphatic system.

Tazerestat works by inhibiting an enzyme calledEZH2. EZH2 is abnormally active in some cancers, causing cancer cells to grow and spread. By inhibiting EZH2, tazerestat can slow or stop the growth of cancer cells and induce their death. Tazerestat has shown significant efficacy in patients with follicular lymphoma, particularly those with mutations in the EZH2 gene. In addition, tazerestat is also used in patients with follicular lymphoma who do not have EZH2 mutations but are resistant to other treatments.

In the treatment of epithelioid sarcoma, tazerestat provides a new treatment option for patients whose tumors cannot be completely removed by surgery. Because these tumors are often difficult to treat, tazetostat provides patients with an effective and convenient oral treatment.

In summary, tazerestat, as an oral drug, brings new hope for the treatment of specific types of cancer by precisely inhibiting theEZH2 enzyme. As more clinical trials are conducted, tazerestat may be used to treat more types of cancer in the future.